{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:54:49Z","timestamp":1785891289286,"version":"3.56.0"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T00:00:00Z","timestamp":1778976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016302","name":"Coalition for Epidemic Preparedness Innovations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016302","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ijid.2026.108810","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:48:44Z","timestamp":1779292124000},"page":"108810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A regional coalition for Lassa fever vaccine development and preparedness in West Africa: A practice-based perspective"],"prefix":"10.1016","volume":"169","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0952-4639","authenticated-orcid":false,"given":"Aishat Bukola","family":"Usman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oyeronke","family":"Oyebanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgil Kuassi","family":"Lokossou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Ramsauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melchior Athanase","family":"Aissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108810_bib0001","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1016\/S2214-109X(25)00450-4","article-title":"Health-economic impacts of age-targeted and sex-targeted Lassa fever vaccination in endemic regions of Nigeria, Guinea, Liberia, and Sierra Leone: a modelling study","volume":"14","author":"Smith","year":"2026","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijid.2026.108810_bib0002","unstructured":"ThisDay Newspaper. https:\/\/www.thisdaylive.com\/2026\/01\/10\/suspected-lassa-fever-claims-four-lives-in-nasarawa\/ 2026. Accessed February 23, 2026."},{"issue":"1","key":"10.1016\/j.ijid.2026.108810_bib0003","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/epirev\/mxz012","article-title":"A global vaccine R&D partnership: driving progress toward epidemic preparedness and response","volume":"41","author":"Gouglas","year":"2019","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.ijid.2026.108810_bib0004","unstructured":"IAVI. First-ever phase 2 Lassa vaccine clinical trial now fully active across West Africa. https:\/\/www.iavi.org\/features\/iavi-c105-lassa-vaccine-clinical-trial-fully-active\/; 2025. Accessed March 3, 2026."},{"key":"10.1016\/j.ijid.2026.108810_bib0005","unstructured":"TGHN. Lassa fever: CEPI technical resources. https:\/\/cepi-tr.tghn.org\/priority-diseases\/lassa\/; 2025. Accessed March 10, 2026."},{"key":"10.1016\/j.ijid.2026.108810_bib0006","unstructured":"CEPI. First volunteer receives Lassa fever vaccine in cutting-edge Oxford trial. https:\/\/cepi.net\/first-volunteer-receives-lassa-fever-vaccine-cutting-edge-oxford-trial; 2025. Accessed March 10, 2026."},{"key":"10.1016\/j.ijid.2026.108810_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2026.108787","article-title":"A prioritised research agenda to inform the introduction and use of Lassa fever vaccines in West Africa","author":"Ko","year":"2026","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ijid.2026.108810_bib0008","unstructured":"CEPI. Ministerial Roundtable on accelerating Lassa Fever vaccine readiness\u2014a strategic moment for regional leadership. Lassa Fever International Conference, Abidjan, 2025. Acessed February 20,2026. https:\/\/static.cepi.net\/downloads\/2025-09\/Communique_Ministerial%20Roundtable%20on%20Accelerating%20Lassa%20Fever%20Vaccine%20Readiness_A%20Strategic%20Moment%20for%20Regional%20Leadership_Sept%208_2025.pdf"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226004455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226004455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:40:53Z","timestamp":1785890453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226004455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":8,"alternative-id":["S1201971226004455"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108810","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A regional coalition for Lassa fever vaccine development and preparedness in West Africa: A practice-based perspective","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108810","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108810"}}